Trial
NCT04904562
Angiotensin II for Distributive Shock
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
La Jolla Pharmaceutical Company
Condition
Distributive Shock
Intervention
Angiotensin II
Why stopped
Enrollment Challenges
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-13